<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2005 (9) TMI 435 - CESTAT, MUMBAI</title>
    <link>https://www.taxtmi.com/caselaws?id=116692</link>
    <description>Neocuron, a pancuronium bromide-based non-depolarising muscle relaxant used as an adjuvant to anaesthesia during surgery, is treated as an anaesthetic for exemption under the cited notifications. The text also notes that final relief depends on verification of whether the approved classification list, earlier accepted without challenge, remained operative during the disputed period; that limited factual question requires fresh decision before consequential relief can follow.</description>
    <language>en-us</language>
    <pubDate>Thu, 15 Sep 2005 00:00:00 +0530</pubDate>
    <lastBuildDate>Thu, 14 Jun 2012 17:56:21 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=153690" rel="self" type="application/rss+xml"/>
    <item>
      <title>2005 (9) TMI 435 - CESTAT, MUMBAI</title>
      <link>https://www.taxtmi.com/caselaws?id=116692</link>
      <description>Neocuron, a pancuronium bromide-based non-depolarising muscle relaxant used as an adjuvant to anaesthesia during surgery, is treated as an anaesthetic for exemption under the cited notifications. The text also notes that final relief depends on verification of whether the approved classification list, earlier accepted without challenge, remained operative during the disputed period; that limited factual question requires fresh decision before consequential relief can follow.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Thu, 15 Sep 2005 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=116692</guid>
    </item>
  </channel>
</rss>